David Turkaly
Stock Analyst at Citizens
(2.14)
# 2,902
Out of 5,129 analysts
144
Total ratings
37.88%
Success rate
-4.06%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Upgrades: Market Outperform | $440 | $361.06 | +21.86% | 4 | Dec 19, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $7 → $5 | $0.82 | +507.16% | 7 | Nov 14, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $3.98 | +101.01% | 6 | Nov 12, 2025 | |
| AXGN Axogen | Maintains: Market Outperform | $26 → $34 | $34.51 | -1.48% | 8 | Oct 30, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $17.08 | +46.37% | 12 | Oct 10, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $67.11 | +8.78% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $13.37 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $88.72 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $59.46 | +68.18% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $244.67 | +14.44% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $10.98 | +127.69% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $22.57 | +143.69% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $140 → $125 | $91.40 | +36.76% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $413.39 | +20.95% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $105.86 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $15.38 | +108.06% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $5.23 | +205.93% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $1.46 | +105.48% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $7.67 | -34.81% | 1 | Oct 6, 2017 |
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $361.06
Upside: +21.86%
TELA Bio
Nov 14, 2025
Maintains: Market Outperform
Price Target: $7 → $5
Current: $0.82
Upside: +507.16%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $3.98
Upside: +101.01%
Axogen
Oct 30, 2025
Maintains: Market Outperform
Price Target: $26 → $34
Current: $34.51
Upside: -1.48%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $17.08
Upside: +46.37%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $67.11
Upside: +8.78%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $13.37
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $88.72
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $59.46
Upside: +68.18%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $244.67
Upside: +14.44%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $10.98
Upside: +127.69%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $22.57
Upside: +143.69%
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $91.40
Upside: +36.76%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $413.39
Upside: +20.95%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $105.86
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $15.38
Upside: +108.06%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $5.23
Upside: +205.93%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $1.46
Upside: +105.48%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $7.67
Upside: -34.81%